Powder: -20°C for 3 years | In solvent: -80°C for 1 year
PFI-4 is a potent and selective and cell-permeable BRPF1 bromodomain inhibitor.
パッケージサイズ | 在庫状況 | 単価(税別) | |||
---|---|---|---|---|---|
サンプルについてお問い合わせ | |||||
5 mg | 在庫あり | ¥ 9,000 | |||
10 mg | 在庫あり | ¥ 15,000 | |||
25 mg | 在庫あり | ¥ 28,000 | |||
50 mg | 在庫あり | ¥ 45,500 | |||
100 mg | 在庫あり | ¥ 75,500 | |||
1 mL * 10 mM (in DMSO) | 在庫あり | ¥ 13,500 |
説明 | PFI-4 is a potent and selective and cell-permeable BRPF1 bromodomain inhibitor. |
ターゲット&IC50 | BRPF3:>10μM, BRPF2:7.9 μM, BRPF1:80 nM |
In vitro | PFI-4 is cell permeable, and acts by displacing the BRPF1 bromodomain from Histone H3.3. [1] |
別名 | PFI4 |
分子量 | 380.44 |
分子式 | C21H24N4O3 |
CAS No. | 900305-37-5 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
H2O: < 1 mg/mL (insoluble or slightly soluble)
DMSO: 14 mg/mL (36.8 mM)
Ethanol: 5 mg/mL (13.14 mM)
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
PFI-4 900305-37-5 Chromatin/Epigenetic Epigenetic Reader Domain bone loss Inhibitor inhibit osteoclasts PFI4 osteolytic malignant bone lesions PFI 4 inhibitor